nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER4—Crohn's disease	0.522	1	CbGaD
Dinoprostone—ABCC5—Mercaptopurine—Crohn's disease	0.148	0.44	CbGbCtD
Dinoprostone—ABCC4—Mercaptopurine—Crohn's disease	0.071	0.212	CbGbCtD
Dinoprostone—SLC22A8—Mercaptopurine—Crohn's disease	0.0444	0.132	CbGbCtD
Dinoprostone—SLCO1B1—Sulfasalazine—Crohn's disease	0.0392	0.117	CbGbCtD
Dinoprostone—SLCO1A2—Prednisone—Crohn's disease	0.0332	0.099	CbGbCtD
Dinoprostone—Misoprostol—PTGER4—Crohn's disease	0.00377	0.916	CrCbGaD
Dinoprostone—SLC51B—digestive system—Crohn's disease	0.00159	0.0474	CbGeAlD
Dinoprostone—PTGER4—epithelium—Crohn's disease	0.00152	0.0455	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—Crohn's disease	0.00147	0.0438	CbGeAlD
Dinoprostone—PTGER2—mammalian vulva—Crohn's disease	0.00134	0.0402	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—Crohn's disease	0.00124	0.0371	CbGeAlD
Dinoprostone—PTGER4—lymphoid tissue—Crohn's disease	0.00117	0.035	CbGeAlD
Dinoprostone—PTGER4—digestive system—Crohn's disease	0.00116	0.0346	CbGeAlD
Dinoprostone—SLC51A—digestive system—Crohn's disease	0.00114	0.034	CbGeAlD
Dinoprostone—HPGDS—epithelium—Crohn's disease	0.00111	0.0333	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—Crohn's disease	0.000992	0.0297	CbGeAlD
Dinoprostone—PTGER3—digestive system—Crohn's disease	0.00098	0.0293	CbGeAlD
Dinoprostone—HPGDS—mammalian vulva—Crohn's disease	0.000965	0.0289	CbGeAlD
Dinoprostone—PTGIR—epithelium—Crohn's disease	0.000907	0.0271	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—Crohn's disease	0.000874	0.0261	CbGeAlD
Dinoprostone—HPGDS—lymphoid tissue—Crohn's disease	0.000857	0.0256	CbGeAlD
Dinoprostone—HPGDS—digestive system—Crohn's disease	0.000847	0.0253	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—Crohn's disease	0.000793	0.0237	CbGeAlD
Dinoprostone—SLCO2A1—skin of body—Crohn's disease	0.000754	0.0225	CbGeAlD
Dinoprostone—SLCO3A1—mammalian vulva—Crohn's disease	0.000695	0.0208	CbGeAlD
Dinoprostone—PTGIR—digestive system—Crohn's disease	0.00069	0.0206	CbGeAlD
Dinoprostone—SLCO2A1—mammalian vulva—Crohn's disease	0.000688	0.0206	CbGeAlD
Dinoprostone—PTGER2—lymph node—Crohn's disease	0.000673	0.0201	CbGeAlD
Dinoprostone—SLC22A11—digestive system—Crohn's disease	0.000673	0.0201	CbGeAlD
Dinoprostone—PTGER4—lymph node—Crohn's disease	0.000661	0.0198	CbGeAlD
Dinoprostone—SLC22A7—digestive system—Crohn's disease	0.000657	0.0196	CbGeAlD
Dinoprostone—SLC51A—lymph node—Crohn's disease	0.000649	0.0194	CbGeAlD
Dinoprostone—SLCO4A1—mammalian vulva—Crohn's disease	0.000633	0.0189	CbGeAlD
Dinoprostone—SLC22A2—digestive system—Crohn's disease	0.000584	0.0175	CbGeAlD
Dinoprostone—PTGER3—lymph node—Crohn's disease	0.00056	0.0167	CbGeAlD
Dinoprostone—SLCO4A1—digestive system—Crohn's disease	0.000555	0.0166	CbGeAlD
Dinoprostone—SLCO1B1—digestive system—Crohn's disease	0.000488	0.0146	CbGeAlD
Dinoprostone—HPGDS—lymph node—Crohn's disease	0.000484	0.0145	CbGeAlD
Dinoprostone—PTGFR—lymph node—Crohn's disease	0.000447	0.0134	CbGeAlD
Dinoprostone—SLCO2B1—digestive system—Crohn's disease	0.000432	0.0129	CbGeAlD
Dinoprostone—SLCO1A2—digestive system—Crohn's disease	0.000397	0.0119	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—Crohn's disease	0.000396	0.0118	CbGeAlD
Dinoprostone—PTGIR—lymph node—Crohn's disease	0.000394	0.0118	CbGeAlD
Dinoprostone—ABCC4—digestive system—Crohn's disease	0.000382	0.0114	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—Crohn's disease	0.000348	0.0104	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—Crohn's disease	0.000347	0.0843	CrCbGaD
Dinoprostone—SLCO2A1—lymph node—Crohn's disease	0.000345	0.0103	CbGeAlD
Dinoprostone—CYP11A1—lymph node—Crohn's disease	0.000341	0.0102	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—Crohn's disease	0.000317	0.00948	CbGeAlD
Dinoprostone—ABCC5—lymph node—Crohn's disease	0.000315	0.00942	CbGeAlD
Dinoprostone—CYP1A2—digestive system—Crohn's disease	0.00026	0.00777	CbGeAlD
Dinoprostone—SLCO2B1—lymph node—Crohn's disease	0.000247	0.00737	CbGeAlD
Dinoprostone—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.000246	0.0279	CcSEcCtD
Dinoprostone—Skin discolouration—Mesalazine—Crohn's disease	0.000245	0.0277	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—Crohn's disease	0.000222	0.00662	CbGeAlD
Dinoprostone—Vaginal inflammation—Mesalazine—Crohn's disease	0.000221	0.0251	CcSEcCtD
Dinoprostone—ABCC4—lymph node—Crohn's disease	0.000218	0.00653	CbGeAlD
Dinoprostone—Vaginal infection—Mesalazine—Crohn's disease	0.000209	0.0237	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000203	0.023	CcSEcCtD
Dinoprostone—Hypertonia—Mesalazine—Crohn's disease	0.000194	0.022	CcSEcCtD
Dinoprostone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000185	0.0209	CcSEcCtD
Dinoprostone—Deafness—Mesalazine—Crohn's disease	0.000179	0.0203	CcSEcCtD
Dinoprostone—Eye pain—Mesalazine—Crohn's disease	0.000178	0.0202	CcSEcCtD
Dinoprostone—Arthralgia—Mercaptopurine—Crohn's disease	0.000151	0.0172	CcSEcCtD
Dinoprostone—Cramp muscle—Mesalazine—Crohn's disease	0.000144	0.0164	CcSEcCtD
Dinoprostone—Asthma—Mesalazine—Crohn's disease	0.000139	0.0157	CcSEcCtD
Dinoprostone—Bronchospasm—Mesalazine—Crohn's disease	0.000136	0.0155	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000132	0.015	CcSEcCtD
Dinoprostone—Hiccups—Prednisone—Crohn's disease	0.000117	0.0133	CcSEcCtD
Dinoprostone—Body temperature increased—Mercaptopurine—Crohn's disease	0.000115	0.013	CcSEcCtD
Dinoprostone—Pharyngitis—Mesalazine—Crohn's disease	0.00011	0.0125	CcSEcCtD
Dinoprostone—Immune system disorder—Azathioprine—Crohn's disease	0.00011	0.0125	CcSEcCtD
Dinoprostone—Chills—Azathioprine—Crohn's disease	0.000109	0.0124	CcSEcCtD
Dinoprostone—Arrhythmia—Azathioprine—Crohn's disease	0.000109	0.0123	CcSEcCtD
Dinoprostone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000107	0.0121	CcSEcCtD
Dinoprostone—Angiopathy—Mesalazine—Crohn's disease	0.000101	0.0114	CcSEcCtD
Dinoprostone—Immune system disorder—Mesalazine—Crohn's disease	0.0001	0.0114	CcSEcCtD
Dinoprostone—Chills—Mesalazine—Crohn's disease	9.95e-05	0.0113	CcSEcCtD
Dinoprostone—Diarrhoea—Mercaptopurine—Crohn's disease	9.93e-05	0.0113	CcSEcCtD
Dinoprostone—Tension—Mesalazine—Crohn's disease	9.47e-05	0.0108	CcSEcCtD
Dinoprostone—Back pain—Mesalazine—Crohn's disease	9.34e-05	0.0106	CcSEcCtD
Dinoprostone—Muscle spasms—Mesalazine—Crohn's disease	9.28e-05	0.0105	CcSEcCtD
Dinoprostone—Vomiting—Mercaptopurine—Crohn's disease	9.23e-05	0.0105	CcSEcCtD
Dinoprostone—Rash—Mercaptopurine—Crohn's disease	9.15e-05	0.0104	CcSEcCtD
Dinoprostone—Dermatitis—Mercaptopurine—Crohn's disease	9.15e-05	0.0104	CcSEcCtD
Dinoprostone—Vision blurred—Mesalazine—Crohn's disease	9.1e-05	0.0103	CcSEcCtD
Dinoprostone—Tremor—Mesalazine—Crohn's disease	9.05e-05	0.0103	CcSEcCtD
Dinoprostone—Arthralgia—Azathioprine—Crohn's disease	9.02e-05	0.0102	CcSEcCtD
Dinoprostone—Myalgia—Azathioprine—Crohn's disease	9.02e-05	0.0102	CcSEcCtD
Dinoprostone—Syncope—Mesalazine—Crohn's disease	8.66e-05	0.00983	CcSEcCtD
Dinoprostone—Nausea—Mercaptopurine—Crohn's disease	8.62e-05	0.00979	CcSEcCtD
Dinoprostone—Loss of consciousness—Mesalazine—Crohn's disease	8.49e-05	0.00963	CcSEcCtD
Dinoprostone—Cough—Mesalazine—Crohn's disease	8.43e-05	0.00956	CcSEcCtD
Dinoprostone—Hypertension—Mesalazine—Crohn's disease	8.34e-05	0.00946	CcSEcCtD
Dinoprostone—Arthralgia—Mesalazine—Crohn's disease	8.22e-05	0.00933	CcSEcCtD
Dinoprostone—Chest pain—Mesalazine—Crohn's disease	8.22e-05	0.00933	CcSEcCtD
Dinoprostone—Myalgia—Mesalazine—Crohn's disease	8.22e-05	0.00933	CcSEcCtD
Dinoprostone—Hypotension—Azathioprine—Crohn's disease	8.08e-05	0.00917	CcSEcCtD
Dinoprostone—Cardiac arrest—Prednisone—Crohn's disease	8.07e-05	0.00915	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	7.88e-05	0.00894	CcSEcCtD
Dinoprostone—Anaphylactic shock—Mesalazine—Crohn's disease	7.88e-05	0.00894	CcSEcCtD
Dinoprostone—Shock—Mesalazine—Crohn's disease	7.75e-05	0.0088	CcSEcCtD
Dinoprostone—Tachycardia—Mesalazine—Crohn's disease	7.69e-05	0.00873	CcSEcCtD
Dinoprostone—Hyperhidrosis—Mesalazine—Crohn's disease	7.62e-05	0.00864	CcSEcCtD
Dinoprostone—Hypotension—Mesalazine—Crohn's disease	7.36e-05	0.00836	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	7.18e-05	0.00815	CcSEcCtD
Dinoprostone—Sweating increased—Prednisone—Crohn's disease	7.14e-05	0.0081	CcSEcCtD
Dinoprostone—Paraesthesia—Mesalazine—Crohn's disease	7.08e-05	0.00803	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Azathioprine—Crohn's disease	7.07e-05	0.00803	CcSEcCtD
Dinoprostone—Dyspnoea—Mesalazine—Crohn's disease	7.03e-05	0.00797	CcSEcCtD
Dinoprostone—Body temperature increased—Azathioprine—Crohn's disease	6.84e-05	0.00776	CcSEcCtD
Dinoprostone—Abdominal pain—Azathioprine—Crohn's disease	6.84e-05	0.00776	CcSEcCtD
Dinoprostone—Pain—Mesalazine—Crohn's disease	6.74e-05	0.00765	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Prednisone—Crohn's disease	6.44e-05	0.00731	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mesalazine—Crohn's disease	6.44e-05	0.00731	CcSEcCtD
Dinoprostone—Myocardial infarction—Prednisone—Crohn's disease	6.41e-05	0.00727	CcSEcCtD
Dinoprostone—Hypersensitivity—Azathioprine—Crohn's disease	6.37e-05	0.00723	CcSEcCtD
Dinoprostone—Abdominal pain—Mesalazine—Crohn's disease	6.23e-05	0.00707	CcSEcCtD
Dinoprostone—Body temperature increased—Mesalazine—Crohn's disease	6.23e-05	0.00707	CcSEcCtD
Dinoprostone—Diarrhoea—Azathioprine—Crohn's disease	5.92e-05	0.00672	CcSEcCtD
Dinoprostone—Hypersensitivity—Mesalazine—Crohn's disease	5.81e-05	0.00659	CcSEcCtD
Dinoprostone—Dizziness—Azathioprine—Crohn's disease	5.72e-05	0.00649	CcSEcCtD
Dinoprostone—Asthenia—Mesalazine—Crohn's disease	5.65e-05	0.00642	CcSEcCtD
Dinoprostone—Vomiting—Azathioprine—Crohn's disease	5.5e-05	0.00624	CcSEcCtD
Dinoprostone—Rash—Azathioprine—Crohn's disease	5.45e-05	0.00619	CcSEcCtD
Dinoprostone—Dermatitis—Azathioprine—Crohn's disease	5.45e-05	0.00618	CcSEcCtD
Dinoprostone—Flushing—Prednisone—Crohn's disease	5.45e-05	0.00618	CcSEcCtD
Dinoprostone—Headache—Azathioprine—Crohn's disease	5.42e-05	0.00615	CcSEcCtD
Dinoprostone—Diarrhoea—Mesalazine—Crohn's disease	5.39e-05	0.00612	CcSEcCtD
Dinoprostone—Angiopathy—Prednisone—Crohn's disease	5.32e-05	0.00604	CcSEcCtD
Dinoprostone—Immune system disorder—Prednisone—Crohn's disease	5.3e-05	0.00601	CcSEcCtD
Dinoprostone—Arrhythmia—Prednisone—Crohn's disease	5.24e-05	0.00595	CcSEcCtD
Dinoprostone—Dizziness—Mesalazine—Crohn's disease	5.21e-05	0.00591	CcSEcCtD
Dinoprostone—Nausea—Azathioprine—Crohn's disease	5.14e-05	0.00583	CcSEcCtD
Dinoprostone—Vomiting—Mesalazine—Crohn's disease	5.01e-05	0.00569	CcSEcCtD
Dinoprostone—Rash—Mesalazine—Crohn's disease	4.97e-05	0.00564	CcSEcCtD
Dinoprostone—Dermatitis—Mesalazine—Crohn's disease	4.96e-05	0.00563	CcSEcCtD
Dinoprostone—Headache—Mesalazine—Crohn's disease	4.94e-05	0.0056	CcSEcCtD
Dinoprostone—Vision blurred—Prednisone—Crohn's disease	4.81e-05	0.00546	CcSEcCtD
Dinoprostone—Nausea—Mesalazine—Crohn's disease	4.68e-05	0.00531	CcSEcCtD
Dinoprostone—Syncope—Prednisone—Crohn's disease	4.58e-05	0.0052	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisone—Crohn's disease	4.49e-05	0.00509	CcSEcCtD
Dinoprostone—Hypertension—Prednisone—Crohn's disease	4.41e-05	0.005	CcSEcCtD
Dinoprostone—Myalgia—Prednisone—Crohn's disease	4.35e-05	0.00494	CcSEcCtD
Dinoprostone—Arthralgia—Prednisone—Crohn's disease	4.35e-05	0.00494	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisone—Crohn's disease	4.17e-05	0.00473	CcSEcCtD
Dinoprostone—Shock—Prednisone—Crohn's disease	4.1e-05	0.00465	CcSEcCtD
Dinoprostone—Tachycardia—Prednisone—Crohn's disease	4.07e-05	0.00462	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisone—Crohn's disease	4.03e-05	0.00457	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Prednisone—Crohn's disease	3.8e-05	0.00431	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisone—Crohn's disease	3.74e-05	0.00425	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Prednisone—Crohn's disease	3.41e-05	0.00387	CcSEcCtD
Dinoprostone—Body temperature increased—Prednisone—Crohn's disease	3.3e-05	0.00374	CcSEcCtD
Dinoprostone—Abdominal pain—Prednisone—Crohn's disease	3.3e-05	0.00374	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisone—Crohn's disease	3.07e-05	0.00349	CcSEcCtD
Dinoprostone—Asthenia—Prednisone—Crohn's disease	2.99e-05	0.00339	CcSEcCtD
Dinoprostone—Diarrhoea—Prednisone—Crohn's disease	2.85e-05	0.00324	CcSEcCtD
Dinoprostone—Dizziness—Prednisone—Crohn's disease	2.76e-05	0.00313	CcSEcCtD
Dinoprostone—Vomiting—Prednisone—Crohn's disease	2.65e-05	0.00301	CcSEcCtD
Dinoprostone—Rash—Prednisone—Crohn's disease	2.63e-05	0.00298	CcSEcCtD
Dinoprostone—Dermatitis—Prednisone—Crohn's disease	2.63e-05	0.00298	CcSEcCtD
Dinoprostone—PTGER2—Signaling by GPCR—IL2RA—Crohn's disease	2.61e-05	0.000271	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	2.61e-05	0.000271	CbGpPWpGaD
Dinoprostone—Headache—Prednisone—Crohn's disease	2.61e-05	0.00296	CcSEcCtD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	2.61e-05	0.000271	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—RASGRP1—Crohn's disease	2.6e-05	0.00027	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PTGER4—Crohn's disease	2.59e-05	0.000269	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL3—Crohn's disease	2.58e-05	0.000267	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	2.57e-05	0.000267	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SLC11A1—Crohn's disease	2.57e-05	0.000267	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—RASGRP1—Crohn's disease	2.53e-05	0.000263	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.53e-05	0.000262	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GPX4—Crohn's disease	2.52e-05	0.000262	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL3—Crohn's disease	2.52e-05	0.000262	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL3—Crohn's disease	2.52e-05	0.000262	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	2.5e-05	0.00026	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—RASGRP1—Crohn's disease	2.49e-05	0.000259	CbGpPWpGaD
Dinoprostone—Nausea—Prednisone—Crohn's disease	2.48e-05	0.00281	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—RBX1—Crohn's disease	2.45e-05	0.000255	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.44e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—RASGRP1—Crohn's disease	2.44e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—RASGRP1—Crohn's disease	2.44e-05	0.000253	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GCKR—Crohn's disease	2.44e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL2RA—Crohn's disease	2.41e-05	0.00025	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	2.39e-05	0.000248	CbGpPWpGaD
Dinoprostone—SLCO1C1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.39e-05	0.000248	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PTGER4—Crohn's disease	2.39e-05	0.000248	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—FADS1—Crohn's disease	2.36e-05	0.000245	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PLA2G4F—Crohn's disease	2.36e-05	0.000245	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—JAK2—Crohn's disease	2.36e-05	0.000245	CbGpPWpGaD
Dinoprostone—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.36e-05	0.000245	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SOCS1—Crohn's disease	2.35e-05	0.000244	CbGpPWpGaD
Dinoprostone—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.34e-05	0.000243	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—UBE2D1—Crohn's disease	2.33e-05	0.000242	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	2.33e-05	0.000242	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.31e-05	0.00024	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—RIPK2—Crohn's disease	2.26e-05	0.000235	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—TYK2—Crohn's disease	2.24e-05	0.000233	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	2.23e-05	0.000232	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—ALB—Crohn's disease	2.23e-05	0.000231	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTMR3—Crohn's disease	2.22e-05	0.000231	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GPX4—Crohn's disease	2.21e-05	0.000229	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—RBX1—Crohn's disease	2.21e-05	0.000229	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HSPA1B—Crohn's disease	2.21e-05	0.000229	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL3—Crohn's disease	2.21e-05	0.000229	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.16e-05	0.000224	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR ligand binding—CXCL8—Crohn's disease	2.16e-05	0.000224	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—UBE2D1—Crohn's disease	2.15e-05	0.000223	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—CXCL8—Crohn's disease	2.15e-05	0.000223	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.15e-05	0.000223	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—JAK2—Crohn's disease	2.14e-05	0.000222	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GCKR—Crohn's disease	2.13e-05	0.000222	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—RASGRP1—Crohn's disease	2.13e-05	0.000221	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR ligand binding—CXCL8—Crohn's disease	2.11e-05	0.000219	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR ligand binding—CXCL8—Crohn's disease	2.11e-05	0.000219	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.1e-05	0.000218	CbGpPWpGaD
Dinoprostone—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.09e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—RIPK2—Crohn's disease	2.09e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—JAK2—Crohn's disease	2.07e-05	0.000215	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	2.05e-05	0.000212	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL3—Crohn's disease	2.03e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SMAD3—Crohn's disease	2.03e-05	0.000211	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCR6—Crohn's disease	2.03e-05	0.000211	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTMR3—Crohn's disease	2.01e-05	0.000208	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2e-05	0.000208	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—IL2RA—Crohn's disease	1.99e-05	0.000206	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCR6—Crohn's disease	1.99e-05	0.000206	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCR6—Crohn's disease	1.99e-05	0.000206	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—RASGRP1—Crohn's disease	1.97e-05	0.000204	CbGpPWpGaD
Dinoprostone—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.97e-05	0.000204	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—CXCL8—Crohn's disease	1.95e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—IL2RA—Crohn's disease	1.94e-05	0.000202	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—IL2RA—Crohn's disease	1.94e-05	0.000202	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—JAK2—Crohn's disease	1.94e-05	0.000201	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—UBE2D1—Crohn's disease	1.93e-05	0.000201	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SOCS1—Crohn's disease	1.93e-05	0.000201	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	1.91e-05	0.000198	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTMR3—Crohn's disease	1.9e-05	0.000197	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL2RA—Crohn's disease	1.88e-05	0.000195	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—TYK2—Crohn's disease	1.84e-05	0.000191	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RBX1—Crohn's disease	1.84e-05	0.00019	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IL2RA—Crohn's disease	1.83e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL2RA—Crohn's disease	1.8e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RBX1—Crohn's disease	1.8e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RBX1—Crohn's disease	1.8e-05	0.000186	CbGpPWpGaD
Dinoprostone—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.79e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTGER4—Crohn's disease	1.79e-05	0.000185	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—JAK2—Crohn's disease	1.79e-05	0.000185	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SOCS1—Crohn's disease	1.78e-05	0.000185	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—CXCL8—Crohn's disease	1.77e-05	0.000183	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL2RA—Crohn's disease	1.77e-05	0.000183	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL2RA—Crohn's disease	1.77e-05	0.000183	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—JAK2—Crohn's disease	1.76e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTGER4—Crohn's disease	1.75e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTGER4—Crohn's disease	1.75e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTMR3—Crohn's disease	1.74e-05	0.000181	CbGpPWpGaD
Dinoprostone—SLCO2B1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.73e-05	0.00018	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—FADS1—Crohn's disease	1.73e-05	0.00018	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.7e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—TYK2—Crohn's disease	1.7e-05	0.000176	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	1.69e-05	0.000175	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.69e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SMAD3—Crohn's disease	1.67e-05	0.000173	CbGpPWpGaD
Dinoprostone—ABCC5—Transmembrane transport of small molecules—ALB—Crohn's disease	1.66e-05	0.000172	CbGpPWpGaD
Dinoprostone—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.64e-05	0.00017	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—CXCL8—Crohn's disease	1.63e-05	0.000169	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTMR3—Crohn's disease	1.62e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—JAK2—Crohn's disease	1.62e-05	0.000168	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GPX4—Crohn's disease	1.62e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—UBE2D1—Crohn's disease	1.61e-05	0.000167	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—CXCL8—Crohn's disease	1.6e-05	0.000167	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—UBE2D1—Crohn's disease	1.58e-05	0.000164	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—UBE2D1—Crohn's disease	1.58e-05	0.000164	CbGpPWpGaD
Dinoprostone—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	1.57e-05	0.000163	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GCKR—Crohn's disease	1.56e-05	0.000162	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—FADS1—Crohn's disease	1.56e-05	0.000162	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RIPK2—Crohn's disease	1.56e-05	0.000162	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2RA—Crohn's disease	1.54e-05	0.00016	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SMAD3—Crohn's disease	1.54e-05	0.00016	CbGpPWpGaD
Dinoprostone—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.53e-05	0.000159	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RIPK2—Crohn's disease	1.53e-05	0.000159	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RIPK2—Crohn's disease	1.53e-05	0.000159	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.53e-05	0.000158	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL3—Crohn's disease	1.52e-05	0.000158	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—ALB—Crohn's disease	1.5e-05	0.000156	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL3—Crohn's disease	1.49e-05	0.000155	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL3—Crohn's disease	1.49e-05	0.000155	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—CXCL8—Crohn's disease	1.48e-05	0.000154	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—FADS1—Crohn's disease	1.48e-05	0.000154	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RASGRP1—Crohn's disease	1.47e-05	0.000153	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GPX4—Crohn's disease	1.46e-05	0.000152	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RASGRP1—Crohn's disease	1.44e-05	0.00015	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RASGRP1—Crohn's disease	1.44e-05	0.00015	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2RA—Crohn's disease	1.43e-05	0.000148	CbGpPWpGaD
Dinoprostone—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	1.42e-05	0.000148	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GCKR—Crohn's disease	1.41e-05	0.000147	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GPX4—Crohn's disease	1.39e-05	0.000144	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SMAD3—Crohn's disease	1.38e-05	0.000144	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—FADS1—Crohn's disease	1.36e-05	0.000141	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GCKR—Crohn's disease	1.34e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—JAK2—Crohn's disease	1.34e-05	0.000139	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.33e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SOCS1—Crohn's disease	1.33e-05	0.000138	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.33e-05	0.000138	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—ALB—Crohn's disease	1.33e-05	0.000138	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TYK2—Crohn's disease	1.33e-05	0.000138	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTGS2—Crohn's disease	1.31e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—JAK2—Crohn's disease	1.31e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—JAK2—Crohn's disease	1.31e-05	0.000136	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SOCS1—Crohn's disease	1.31e-05	0.000135	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SOCS1—Crohn's disease	1.31e-05	0.000135	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—TYK2—Crohn's disease	1.27e-05	0.000132	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX4—Crohn's disease	1.27e-05	0.000132	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—JAK2—Crohn's disease	1.26e-05	0.000131	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—FADS1—Crohn's disease	1.26e-05	0.000131	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—TYK2—Crohn's disease	1.24e-05	0.000129	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—TYK2—Crohn's disease	1.24e-05	0.000129	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.24e-05	0.000129	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—JAK2—Crohn's disease	1.23e-05	0.000128	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GCKR—Crohn's disease	1.23e-05	0.000127	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—CXCL8—Crohn's disease	1.22e-05	0.000127	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—JAK2—Crohn's disease	1.21e-05	0.000126	CbGpPWpGaD
Dinoprostone—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.2e-05	0.000124	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—CXCL8—Crohn's disease	1.19e-05	0.000124	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—CXCL8—Crohn's disease	1.19e-05	0.000124	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—JAK2—Crohn's disease	1.19e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—JAK2—Crohn's disease	1.19e-05	0.000123	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX4—Crohn's disease	1.18e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CXCL8—Crohn's disease	1.15e-05	0.00012	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMAD3—Crohn's disease	1.15e-05	0.00012	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	1.15e-05	0.000119	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GCKR—Crohn's disease	1.14e-05	0.000119	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMAD3—Crohn's disease	1.13e-05	0.000117	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMAD3—Crohn's disease	1.13e-05	0.000117	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.12e-05	0.000116	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CXCL8—Crohn's disease	1.11e-05	0.000115	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—Crohn's disease	1.1e-05	0.000114	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TYK2—Crohn's disease	1.09e-05	0.000113	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CXCL8—Crohn's disease	1.08e-05	0.000112	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CXCL8—Crohn's disease	1.08e-05	0.000112	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2RA—Crohn's disease	1.07e-05	0.000111	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.06e-05	0.00011	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2RA—Crohn's disease	1.04e-05	0.000108	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2RA—Crohn's disease	1.04e-05	0.000108	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—JAK2—Crohn's disease	1.04e-05	0.000108	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.01e-05	0.000105	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TYK2—Crohn's disease	1e-05	0.000104	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	9.99e-06	0.000104	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.78e-06	0.000102	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—JAK2—Crohn's disease	9.58e-06	9.95e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.56e-06	9.93e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CXCL8—Crohn's disease	9.48e-06	9.84e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—STAT3—Crohn's disease	9.28e-06	9.63e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.09e-06	9.44e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TYK2—Crohn's disease	9.03e-06	9.37e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—Crohn's disease	9.01e-06	9.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	8.93e-06	9.27e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.84e-06	9.18e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CXCL8—Crohn's disease	8.74e-06	9.08e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—JAK2—Crohn's disease	8.61e-06	8.94e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.37e-06	8.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.33e-06	8.65e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—Crohn's disease	8.32e-06	8.63e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CD4—Crohn's disease	8.16e-06	8.47e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—Crohn's disease	8.1e-06	8.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.77e-06	8.06e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ALB—Crohn's disease	7.76e-06	8.05e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—STAT3—Crohn's disease	7.62e-06	7.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTMR3—Crohn's disease	7.59e-06	7.88e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TYK2—Crohn's disease	7.51e-06	7.8e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TYK2—Crohn's disease	7.35e-06	7.63e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TYK2—Crohn's disease	7.35e-06	7.63e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JAK2—Crohn's disease	7.16e-06	7.44e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—Crohn's disease	7.03e-06	7.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JAK2—Crohn's disease	7.01e-06	7.28e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JAK2—Crohn's disease	7.01e-06	7.28e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—Crohn's disease	6.79e-06	7.05e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—Crohn's disease	6.79e-06	7.05e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—Crohn's disease	6.54e-06	6.79e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—Crohn's disease	6.48e-06	6.73e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—Crohn's disease	6.4e-06	6.64e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—Crohn's disease	6.4e-06	6.64e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—Crohn's disease	6.32e-06	6.56e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—Crohn's disease	6.22e-06	6.45e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—Crohn's disease	6.09e-06	6.32e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—Crohn's disease	6.09e-06	6.32e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—Crohn's disease	5.94e-06	6.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FADS1—Crohn's disease	5.91e-06	6.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX4—Crohn's disease	5.54e-06	5.75e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCKR—Crohn's disease	5.35e-06	5.55e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—Crohn's disease	5.32e-06	5.53e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—Crohn's disease	5.26e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—Crohn's disease	5.15e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—Crohn's disease	5.15e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—Crohn's disease	4.98e-06	5.17e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—Crohn's disease	4.91e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—Crohn's disease	4.5e-06	4.67e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—Crohn's disease	4.42e-06	4.58e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—Crohn's disease	4.36e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—Crohn's disease	4.26e-06	4.42e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—Crohn's disease	3.94e-06	4.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—Crohn's disease	3.9e-06	4.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.82e-06	3.97e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—Crohn's disease	3.73e-06	3.87e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—Crohn's disease	3.67e-06	3.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—Crohn's disease	3.64e-06	3.78e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—Crohn's disease	3.6e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—Crohn's disease	3.6e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—Crohn's disease	3.41e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.34e-06	3.47e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—Crohn's disease	3.18e-06	3.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—Crohn's disease	1.7e-06	1.77e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.49e-06	1.55e-05	CbGpPWpGaD
